Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Angiodynamics (ANGO) FCF Margin (2016 - 2025)

Historic FCF Margin for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to 4.36%.

  • Angiodynamics' FCF Margin rose 25600.0% to 4.36% in Q4 2025 from the same period last year, while for Nov 2025 it was 3.13%, marking a year-over-year increase of 60500.0%. This contributed to the annual value of 4.99% for FY2025, which is 51000.0% up from last year.
  • According to the latest figures from Q4 2025, Angiodynamics' FCF Margin is 4.36%, which was up 25600.0% from 22.1% recorded in Q3 2025.
  • Angiodynamics' FCF Margin's 5-year high stood at 22.72% during Q2 2025, with a 5-year trough of 33.92% in Q3 2023.
  • Moreover, its 5-year median value for FCF Margin was 0.83% (2023), whereas its average is 4.23%.
  • Per our database at Business Quant, Angiodynamics' FCF Margin skyrocketed by 343600bps in 2021 and then tumbled by -202000bps in 2022.
  • Over the past 5 years, Angiodynamics' FCF Margin (Quarter) stood at 0.99% in 2021, then surged by 841bps to 7.36% in 2022, then crashed by -30bps to 5.12% in 2023, then crashed by -65bps to 1.8% in 2024, then surged by 143bps to 4.36% in 2025.
  • Its FCF Margin was 4.36% in Q4 2025, compared to 22.1% in Q3 2025 and 22.72% in Q2 2025.